Hypomethylating Agent Maintenance for Favorable and Intermediate Risk Acute Myeloid Leukemia

被引：0
|
作者：
Singh, Reema [1 ]
Halder, Rohan [1 ]
Verma, Megha [1 ]
Mehta, Pallavi [1 ]
Agrawal, Narendra [1 ]
Ahmed, Rayaz [1 ]
Bhurani, Dinesh [1 ]
机构：
[1] Rajiv Gandhi Canc Inst & Res Ctr, Dept Hematooncol & BMT, New Delhi, India
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-162124
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11713 / 11715
页数：3
相关论文
共 50 条
  • [1] Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia
    Arslan, Shukaib
    Zhang, Jianying
    Dhakal, Prajwal
    Moran, Jenna
    Naidoo, Nuthana
    Lombardi, Jennifer
    Pullarkat, Vinod
    Stein, Anthony S.
    Marcucci, Guido
    Yaghmour, George
    Bhatt, Vijaya R.
    Fathi, Amir T.
    Aldoss, Ibrahim
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (03) : E59 - E63
  • [2] ELN 2022 Favorable Genetic Risk Acute Myeloid Leukemia Treated with Venetoclax Plus Hypomethylating Agent: Predictors of Response and Survival
    McCullough, Kristen
    Karrar, Omer
    Iftikhar, Moazah
    Abdelmagid, Maymona
    Al-Kali, Aref
    Alkhateeb, Hassan
    Begna, Kebede
    Mangaonkar, Abhishek A.
    Saliba, Antoine
    Hefazi, Mehrdad
    Litzow, Mark R.
    Hogan, William J.
    Shah, Mithun V.
    Patnaik, Mrinal M.
    Pardanani, Animesh D.
    Tefferi, Ayalew
    Gangat, Naseema
    BLOOD, 2023, 142
  • [3] Venetoclax combined with hypomethylating agents for favorable risk acute myeloid leukemia: A single center experience
    Bajwa, Shammas
    Parkin, Brian
    Gayle, Arlene A.
    Patel, Rushang D.
    Mori, Shahram
    Pancari, Philip
    Socola, Francisco Andres
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Oral Azacitidine Maintenance Therapy in Acute Myeloid Leukemia after Frontline Hypomethylating Agent and Venetoclax
    Canavan, Cody
    Knight, Thomas G.
    Shah, Nilay A.
    Chojecki, Aleksander L.
    Ai, Jing
    Levine, Jonathan K.
    Osei-Boateng, Kwabena
    Hiremath, Adarsh
    Grunwald, Michael R.
    BLOOD, 2024, 144 : 6036 - 6037
  • [5] Outcomes of Therapy with Venetoclax Combined with Hypomethylating Agents in Favorable-Risk Acute Myeloid Leukemia (AML)
    Arslan, Shukaib
    Zhang, Jianying
    Dhakal, Prajwal
    Moran, Jenna A.
    Naidoo, Nuthana
    Story, Jennifer Lombardi
    Pullarkat, Vinod A.
    Stein, Anthony S.
    Marcucci, Guido
    Yaghmour, George
    Bhatt, Vijaya R.
    Fathi, Amir T.
    Aldoss, Ibrahim
    BLOOD, 2020, 136
  • [6] Mutational correlates of response to hypomethylating agent therapy in acute myeloid leukemia
    Coombs, Catherine C.
    Sallman, David A.
    Devlin, Sean M.
    Dixit, Shweta
    Mohanty, Abhinita
    Knapp, Kristina
    Al Ali, Najla H.
    Lancet, Jeffrey E.
    List, Alan F.
    Komrokji, Rami S.
    Padron, Eric
    Arcila, Maria E.
    Klimek, Virginia M.
    van den Brink, Marcel R. M.
    Tallman, Martin S.
    Levine, Ross L.
    Rampal, Raajit K.
    Rapaport, Franck
    HAEMATOLOGICA, 2016, 101 (11) : E457 - E460
  • [7] Gemtuzumab Ozogamicin in Favorable and Intermediate Risk Acute Myeloid Leukemia: A Single-Center Experience
    Liu, Jia Li
    Sadeghi, Nushin
    Luo, Owen
    How, Jonathan
    Storring, John M.
    Popradi, Gizelle
    BLOOD, 2024, 144 : 6029 - 6030
  • [8] Time to response and survival in hypomethylating agent-treated acute myeloid leukemia
    Boddu, Prajwal
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Jabbour, Elias
    Borthakur, Gautam
    Daver, Naval
    Pemmaraju, Naveen
    Pierce, Sherry
    Cortes, Jorge
    Kadia, Tapan M.
    LEUKEMIA & LYMPHOMA, 2018, 59 (04) : 1012 - 1015
  • [9] Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax plus Hypomethylating Agent
    Gangat, Naseema
    Elbeih, Azeem
    Ghosoun, Nour
    Mccullough, Kristen
    Aperna, Fnu
    Johnson, Isla M.
    Abdelmagid, Maymona
    Al-Kali, Aref
    Alkhateeb, Hassan B.
    Begna, Kebede H.
    Elliott, Michelle
    Mangaonkar, Abhishek
    Matin, Aasiya
    Saliba, Antoine N.
    Torghabeh, Mehrdad Hefazi
    Litzow, Mark R.
    Hogan, William
    Shah, Mithun
    Patnaik, Mrinal M.
    Pardanani, Animesh
    Badar, Talha
    Murthy, Hemant
    Foran, James
    Palmer, Jeanne
    Sproat, Lisa
    Khera, Nandita
    Yi, Cecilia Arana
    Yates, Samuel
    Sneider, Abigail
    Dworkin, Emily
    Patel, Anand A.
    Bazinet, Alexandre
    Senapati, Jayastu
    Bataller, Alex
    Dinardo, Courtney
    Kadia, Tapan
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (02) : 260 - 271
  • [10] Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia
    DiNardo, Courtney D.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (02) : 82 - 83
12345